- High gross margin of 77.1%
- Consistently positive technical signals over the last month
- Highly efficient cash conversion (100% FCF/OCF ratio)
Green day on Wednesday for ARS Pharmaceuticals, Inc. stock after gaining 2.06%
(Updated on Jun 17, 2026)
The ARS Pharmaceuticals, Inc. stock price gained 2.06% on the last trading day (Wednesday, 17th Jun 2026), rising from $9.70 to $9.90. During the last trading day the stock fluctuated 4.57% from a day low at $9.71 to a day high of $10.16. The price has risen in 7 of the last 10 days and is up by 13.14% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 131 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $9.95 million.
The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $9.88, a level that may pose a second chance to hit a runner. According to fan-theory $12.18 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
SPRY Signals & Forecast
Mostly positive signals in the chart today. The ARS Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.63 and $8.71. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 38.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for ARS Pharmaceuticals, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $8.56 and $8.30. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ARS Pharmaceuticals, Inc. finds support just below today's level at $8.56. If this is broken, then the next support from accumulated volume will be at $8.30 and $7.94.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.444 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 4.92%.
Our recommended stop-loss: $9.32 (-5.88%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 20 days ago.)
Trading Expectations (SPRY) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect ARS Pharmaceuticals, Inc. to open at $9.92, and during the day (based on 14 day Average True Range), to move between $9.62 and $10.18, which gives a possible trading interval of +/-$0.563 (+/-5.85%) up or down from last closing price. If ARS Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 5.85% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $8.56, some $1.34 (13.54%) from the current price of $9.90, our system finds the risk reward attractive.
Is ARS Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and the stock has broken the rising trend up, which indicates an even stronger rate of rising. We can conclude that the current level may hold a buying opportunity as there is a fair chance for ARS Pharmaceuticals, Inc. stock to perform well in the short-term period. Due to a possible false trend-break listing stock as pure buy candidate is held back.
Current score:
4.688
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 18, 2026 - $9.92 ( 0.222%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SPRY Performance
Trading levels for SPRY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 10.37 | 4.71% |
| R2 | 10.20 | 2.99% |
| R1 | 10.09 | 1.94% |
| Price | 9.90 | |
| S1 | 9.75 | -1.49% |
| S2 | 9.65 | -2.55% |
| S3 | 9.48 | -4.26% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 9.90 | |
| S1 | 8.56 | -13.54% |
| S2 | 8.30 | -16.16% |
| S3 | 7.94 | -19.80% |
FAQ
Click here for our free guide on how to buy ARS Pharmaceuticals, Inc. Stock.
Buy SPRY